Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance

E-ISSN： 1532-6535|93|3|252-259

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.93, Iss.3, 2013-03, pp. : 252-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk-based and diagnostics-linked personalized medicine for cancer

By Srivastava Sudhir Wagner Paul D

Personalized Medicine, Vol. 4, Iss. 1, 2007-02 ,pp. : 33-43

Future Medicine

Access to resources Recommend Favorite

Breath biomarkers for personalized medicine

By Modak Anil S

Personalized Medicine, Vol. 7, Iss. 6, 2010-11 ,pp. : 643-653

Future Medicine

Access to resources Recommend Favorite

Molecular classification of idiopathic pulmonary fibrosis: Personalized medicine, genetics and biomarkers

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 7, 2015-10 ,pp. : 1010-1022

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development and validation of risk models and molecular diagnostics to permit personalized management of cancer

CANCER, Vol. 120, Iss. 1, 2014-01 ,pp. : 11-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

Personalized Cancer Medicine

Oncology Research and Treatment, Vol. 35, Iss. 1, 2012-01 ,pp. : 2-2

Karger

Access to resources Recommend Favorite